Bristol's Merger With Celgene Is Already Paying Dividends: CEO
Bristol-Myers Squibb Co., fresh off completing one of the largest drug-industry mergers ever, is counting on the acquisition to pay off quickly with new products and ease Wall Street concerns...
Related Articles
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- 2 Gender-Diversity Trends in the Corporate Boardroom also published in morningstar.com
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Nokia Board Has Discussed Pursuit of Alcatel also mentions acquisition
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- Good Corporate Governance Benefits Shareholders also published in morningstar.com
Login to comment.